Full Text View
Tabular View
No Study Results Posted
Related Studies
Treating Drug-Resistant Childhood Schizophrenia
This study has been completed.
Study NCT00048828   Information provided by National Institute of Mental Health (NIMH)
First Received: November 8, 2002   Last Updated: April 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Additional conditions recognized in this trial
Schizophrenia, Childhood
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Olanzapine
Clozapine
More general drug interventions related to this trial
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services